Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The cream with turmeric and ginger extracts can potentially reduce underarm hair growth effectively.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Nanostructured Lipid Carriers can improve curcumin's effectiveness for treating hair loss.

Clascoterone cream could be used for other skin conditions affected by hormones.

A woman had an allergic skin reaction to a hair loss treatment containing canrenone.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Personalized acne treatments and new therapies show promise for better results.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Minoxidil effectively treats hair loss, with better results in women.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

A woman with severe angioedema improved significantly after treatment with rituximab.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Minoxidil can cause unwanted hair growth, so personalized care and support are important.

Clascoterone may be an effective topical treatment for hair loss.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

Topical finasteride may help treat facial hirsutism in women.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

PCOS management involves medication, lifestyle changes, and personalized treatment to address symptoms and improve health.

Choosing the right estroprogestin is crucial for effectively managing PCOS symptoms.

Minoxidil and finasteride are key treatments for hair loss.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Anti-androgens can help reduce the effects of male hormones on the skin.

Spironolactone reduces hair growth in women with unexplained excessive hairiness.